Bluestar Genomics reports new method for early pancreatic cancer detection
Validation of Bluestar Genomics’ technology for non-invasive detection of pancreatic cancer is published in Nature Communications
Cancer Research
A margetuximab agreement for MacroGenics and EVERSANA
MacroGenics and EVERSANA announce approval-dependent agreement to support launch and commercialization of margetuximab
Taking cancer care to the next level
OneOncology and Genentech announce a multi-year partnership to improve clinical trials, boost comprehensive genomic profiling
Focus Feature on Cancer Research News: Cellular insights into cancer
Understanding behavior, responses and evolution of cells aids in oncology efforts
Getting the lowdown on GLO2
Researchers publish new data on the enzyme glyoxalase II and its role in cellular metabolism
Preclinical pancreatic cancer partnership
Relationship targets use of pipeline drug and AI platform
Targeting PVRIG in cancer immunotherapy
Expression data suggest potential of PVRIG inhibition to enhance T cell priming and infiltration into both inflamed and less inflamed tumors
Returning to the fold
Illumina acquires cancer-focused GRAIL for $8 billion
Perturbing proteins
MD Anderson team studies how proteins respond to treatment in more than 300 cancer cell lines
NanoDeep analysis method expands super-resolution microscopy applications
New analysis method from Karolinska Institutet increases the number of proteins that can be analyzed simultaneously
Nucleic acids, virotherapy and liver cancer
As part of awards grant, Combined Therapeutics will receive in-kind MilliporeSigma products, consultation in downstream processing and more
